Publisher
Springer Berlin Heidelberg
Reference17 articles.
1. Buehler PW, Alayash AI (2008) All hemoglobin-based oxygen carriers are not created equally. Biochim Biophys Acta 1784(10):1378–81, Oct 2008, Epub 3 Jan. 2008
2. Buehler PW, D’Agnillo F, Schaer DJ (2010) Hemoglobin-based oxygen carriers: from mechanisms of toxicity and clearance to rational drug design. Trends Mol Med. 16(10):447–57, 2010, Epub 13 Aug 2010
3. Chen JY, Scerbo M, Kramer G (2009) A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers. CLINICS 64(8):803–813
4. Guidance for Industry (2004) Criteria for safety and efficacy evaluation of oxygen therapeutics as red blood cell substitutes, Draft Guidance, Oct 2004
5. Guidance for Industry (2008) CGMP for Phase 1 investigational drugs, July 2008